The effectiveness of ruxolitinib and cyclophosphamide combination on T helper 17 and regulatory T cells in rat experimental membranous glomerulonephritis

The progression and pathogenesis of membranous glomerulonephritis (MGN) are inextricably linked to chronic inflammation. Despite improving clinical remission rates due to the application of cyclophosphamide (CYC), treatment of MGN still requires further exploration. Ruxolitinib (Ruxo) negatively aff...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rahim Iranzad, Maryam Hosseini, Mahdi Bagheri, Mohammad Sadegh Soltani-Zangbar, Mohammadbagher Pirouzpanah, Negin Biglari, Mohammadali Zolfaghari, Arash Khaki, Leili Aghebati-Maleki, Leila Roshangar, Elham Badihi, Farshid Afandideh, Reihane Shahabirad, Ali Akbar Shekarchi, Javad Ahmadian Heris, Jalal Etemadi, Mehdi Yousefi
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-08-01
Col·lecció:	Molecular and Cellular Probes
Matèries:	Cyclophosphamide Glomerulonephritis Ruxolitinib T helper 17 cells Regulatory T cells
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S0890850824000215
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!